keyword
MENU ▼
Read by QxMD icon Read
search

cardiology update

keyword
https://read.qxmd.com/read/30760415/2019-canadian-cardiovascular-society-canadian-association-of-interventional-cardiology-guidelines-on-the-acute-management-of-st-elevation-myocardial-infarction-focused-update-on-regionalization-and-reperfusion
#1
Graham C Wong, Michelle Welsford, Craig Ainsworth, Wael Abuzeid, Christopher B Fordyce, Jennifer Greene, Thao Huynh, Laurie Lambert, Michel Le May, Sohrab Lutchmedial, Shamir R Mehta, Madhu Natarajan, Colleen M Norris, Christopher B Overgaard, Michele Perry Arnesen, Ata Quraishi, Jean François Tanguay, Mouheiddin Traboulsi, Sean van Diepen, Robert Welsh, David A Wood, Warren J Cantor
Rapid reperfusion of the infarct-related artery is the cornerstone of therapy for the management of acute ST-elevation myocardial infarction (STEMI). Canada's geography presents unique challenges for timely delivery of reperfusion therapy for STEMI patients. The Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology STEMI guideline was developed to provide advice regarding the optimal acute management of STEMI patients irrespective of where they are initially identified: in the field, at a non-percutaneous coronary intervention-capable centre or at a percutaneous coronary intervention-capable centre...
February 2019: Canadian Journal of Cardiology
https://read.qxmd.com/read/30746243/clinical-manifestations-diagnosis-and-treatment-of-ischemic-mitral-regurgitation-a-review
#2
REVIEW
Néstor Báez-Ferrer, María Manuela Izquierdo-Gómez, Belén Marí-López, Javier Montoto-López, Amelia Duque-Gómez, Javier García-Niebla, Julio Miranda-Bacallado, Alejandro de la Rosa Hernández, Ignacio Laynez-Cerdeña, Juan Lacalzada-Almeida
Ischemic mitral regurgitation (IMR) is a frequent complication after acute myocardial infarction (AMI) associated with a worse prognosis. The pathophysiological mechanisms of IMR are not fully understood, but it is known to be a complex process in which ventricular remodelling is the main causal factor. The various imaging techniques in cardiology and echocardiography fundamentally have contributed significantly to clarify the mechanisms that cause and progressively aggravate IMR. At present, different therapeutic options, the most important of which are cardio-surgical, address this problem...
December 2018: Journal of Thoracic Disease
https://read.qxmd.com/read/30740318/improving-medical-care-and-prevention-in-adults-with-congenital-heart-disease-reflections-on-a-global-problem-part-i-development-of-congenital-cardiology-epidemiology-clinical-aspects-heart-failure-cardiac-arrhythmia
#3
REVIEW
Rhoia Neidenbach, Koichiro Niwa, Oeztekin Oto, Erwin Oechslin, Jamil Aboulhosn, David Celermajer, Joerg Schelling, Lars Pieper, Linda Sanftenberg, Renate Oberhoffer, Fokko de Haan, Michael Weyand, Stephan Achenbach, Christian Schlensak, Dirk Lossnitzer, Nicole Nagdyman, Yskert von Kodolitsch, Hans-Carlo Kallfelz, David Pittrow, Ulrike M M Bauer, Peter Ewert, Thomas Meinertz, Harald Kaemmerer
Today most patients with congenital heart defects (CHD) survive into adulthood. Unfortunately, despite relevant residua and sequels, follow-up care of adults with congenital heart disease (ACHD) is not performed in specialized and/or certified physicians or centres. Major problems in the long-term course encompass heart failure, cardiac arrhythmias, heart valve disorders, pulmonary vascular disease, infective endocarditis, aortopathy and non-cardiac comorbidities. Many of them manifest themselves differently from acquired heart disease and therapy regimens from general cardiology cannot be transferred directly to CHD...
December 2018: Cardiovascular Diagnosis and Therapy
https://read.qxmd.com/read/30737057/how-low-to-go-with-lipid-lowering-therapies-in-a-cost-effective-and-prudent-manner
#4
REVIEW
Rhanderson Cardoso, Roger S Blumenthal, Stephen Kopecky, Francisco Lopez-Jimenez, Seth S Martin
The 2013 American College of Cardiology/American Heart Association guideline on the treatment of blood cholesterol was a landmark document guiding health care professionals around the globe on how to administer lipid-lowering therapies. Those guidelines were primarily focused on statin therapy benefit groups. The writing committee found insufficient evidence for specific low-density lipoprotein cholesterol (LDL-C) treatment targets. There have been many important updates in the lipid literature since the publication of that document...
February 6, 2019: Mayo Clinic Proceedings
https://read.qxmd.com/read/30703812/management-of-patients-with-asymptomatic-and-symptomatic-carotid-artery-disease-update-on-anti-thrombotic-therapy
#5
Daniele Pastori, John W Eikelboom, Sonia S Anand, Manesh Raman Patel, Jean-Francois Tanguay, Jean-Baptiste Ricco, Eike Sebastian Debus, Lucia Mazzolai, Rupert Bauersachs, Peter Verhamme, Jackie Bosch, Sigrid Nikol, Mark Nehler, Victor Aboyans, Francesco Violi
The most common causes of ischaemic stroke are represented by carotid artery atherosclerotic disease (CAAD) and atrial fibrillation. While oral anticoagulants substantially reduce the incidence of thromboembolic stroke (< 1%/year), the rate of ischaemic stroke and other cardiovascular disease events in patients with CAAD remains high, ranging from 8.4 to 18.1 events per 100 patient-years. Similar to any other atherosclerotic disease, anti-thrombotic therapies are proposed for CAAD to reduce stroke and other cardiovascular events...
January 31, 2019: Thrombosis and Haemostasis
https://read.qxmd.com/read/30703530/2019-aha-acc-hrs-focused-update-of-the-2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-fibrillation-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines-and-the-heart-rhythm
#6
Craig T January, L Samuel Wann, Hugh Calkins, Michael E Field, Lin Y Chen, Karen L Furie, Joaquin E Cigarroa, Paul A Heidenreich, Joseph C Cleveland, Katherine T Murray, Patrick T Ellinor, Julie B Shea, Michael D Ezekowitz, Cynthia M Tracy, Clyde W Yancy
No abstract text is available yet for this article.
January 23, 2019: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/30703431/2019-aha-acc-hrs-focused-update-of-the-2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-fibrillation-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines-and-the-heart-rhythm
#7
Craig T January, L Samuel Wann, Hugh Calkins, Lin Y Chen, Joaquin E Cigarroa, Joseph C Cleveland, Patrick T Ellinor, Michael D Ezekowitz, Michael E Field, Karen L Furie, Paul A Heidenreich, Katherine T Murray, Julie B Shea, Cynthia M Tracy, Clyde W Yancy
No abstract text is available yet for this article.
January 21, 2019: Journal of the American College of Cardiology
https://read.qxmd.com/read/30651157/south-african-dyslipidaemia-guideline-consensus-statement-2018-update-a-joint-statement-from-the-south-african-heart-association-sa-heart-and-the-lipid-and-atherosclerosis-society-of-southern-africa-lassa
#8
E Klug, F J Raal, A D Marais, C M Smuts, C Schamroth, D Jankelow, D J Blom, D A Webb
South Africa (SA) is home to a heterogeneous population with a wide range of cardiovascular risk factors. Cholesterol reduction in combination with aggressive management of modifiable risk factors, including nutrition, physical activity, blood pressure and smoking, can help to reduce and prevent morbidity and mortality in individuals who are at increased risk of cardiovascular events. This updated consensus guide to management of dyslipidaemia in SA is based on the updated European Society of Cardiology and European Atherosclerosis Society dyslipidaemia guidelines published in 2016...
October 26, 2018: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
https://read.qxmd.com/read/30645967/south-african-dyslipidaemia-guideline-consensus-statement-2018-update-a-joint-statement-from-the-south-african-heart-association-sa-heart-and-the-lipid-and-atherosclerosis-society-of-southern-africa-lassa
#9
E Klug, F J Raal, A D Marais, C M Smuts, C Schamroth, D Jankelow, D J Blom, D A Webb
South Africa (SA) is home to a heterogeneous population with a wide range of cardiovascular risk factors. Cholesterol reduction in combination with aggressive management of modifiable risk factors, including nutrition, physical activity, blood pressure and smoking, can help to reduce and prevent morbidity and mortality in individuals who are at increased risk of cardiovascular events. This updated consensus guide to management of dyslipidaemia in SA is based on the updated European Society of Cardiology and European Atherosclerosis Society dyslipidaemia guidelines published in 2016...
October 26, 2018: South African Medical Journal, Suid-Afrikaanse Tydskrif Vir Geneeskunde
https://read.qxmd.com/read/30632389/interobserver-variability-in-applying-american-society-of-echocardiography-european-association-of-cardiovascular-imaging-2016-guidelines-for-estimation-of-left-ventricular-filling-pressure
#10
Sherif F Nagueh, Theodore P Abraham, Gerard P Aurigemma, Jeroen J Bax, Carmen Beladan, Alyssa Browning, Mohammed A Chamsi-Pasha, Victoria Delgado, Genevieve Derumeaux, Giulia Dolci, Erwan Donal, Thor Edvardsen, Kinan Carlos El Tallawi, Laura Ernande, Roberta Esposito, Frank A Flachskampf, Maurizio Galderisi, James Gentry, Steven A Goldstein, Serge C Harb, Arnaud Hubert, Judy Hung, Allan L Klein, Patrizio Lancellotti, Redah Z Mahmood, Paolo Marino, Bogdan A Popescu, Martina Previato, Saket R Sanghai, Otto A Smiseth, Jiaqiong Xu
BACKGROUND: Assessment of left ventricular (LV) filling pressure is among the important components of a comprehensive echocardiographic report. Previous studies noted wide limits of agreement using 2009 American Society of Echocardiography/European Association of Echocardiography guidelines, but reproducibility of 2016 guidelines update in estimating LV filling pressure is unknown. METHODS: Echocardiographic and hemodynamic data were obtained from 50 patients undergoing cardiac catheterization for clinical indications...
December 2019: Circulation. Cardiovascular Imaging
https://read.qxmd.com/read/30625082/review-of-new-american-heart-association-american-college-of-cardiology-heart-rhythm-society-guideline-for-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-of-sudden-cardiac-death
#11
N Yu Mironov, S P Golitsyn
In this brief review we focus on major updates and key points of 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
November 24, 2018: Kardiologiia
https://read.qxmd.com/read/30624184/hypertension-guidelines-treat-patients-not-numbers
#12
REVIEW
Wesam Aleyadeh, Erika Hutt-Centeno, Haitham M Ahmed, Nishant P Shah
The updated 2017 American College of Cardiology and American Heart Association (ACC/AHA) guidelines for managing hypertension advocate tighter blood pressure control than previous guidelines. This review summarizes the evidence behind the guidelines, discusses the risks and benefits of stricter blood pressure control, and provides our insights on blood pressure management in clinical practice.
January 2019: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/30608884/strength-of-evidence-underlying-the-american-heart-association-american-college-of-cardiology-guidelines-on-endovascular-and-surgical-treatment-of-peripheral-vascular-disease
#13
Partha Sardar, Jay Giri, Michael R Jaff, Sahil A Parikh, Amartya Kundu, Christopher J White, Saurav Chatterjee, Kevin F Kennedy, Nihar R Desai, Omar N Hyder, Debabrata Mukherjee, Mehdi H Shishehbor, J Dawn Abbott, Herbert D Aronow
BACKGROUND: The objective of this study was to evaluate the evidence-base supporting the American Heart Association and American College of Cardiology guidelines on peripheral vascular interventions. METHODS AND RESULTS: American Heart Association/American College of Cardiology guideline documents available as of May 2018 were abstracted for both endovascular and surgical peripheral vascular intervention. The number of recommendations, class of recommendations (I, II, and III) and the distribution of their respective level of evidence (LOE; A, B, and C) were determined for each procedure...
January 2019: Circulation. Cardiovascular Interventions
https://read.qxmd.com/read/30604199/highlights-of-esc-esh-2018-guidelines-on-the-management-of-hypertension-what-every-doctor-should-know
#14
REVIEW
Massimo Volpe, Giovanna Gallo, Allegra Battistoni, Giuliano Tocci
This is a review article aiming to make focus on the changes made in the most recent sets of clinical recommendations and indications from European Society of Cardiology (ESC)/European Society of Hypertension (ESH) guidelines for the management of arterial hypertension. In particular, in this article we attempted to focus on the main new elements introduced in order to meet the need of doctors to adhere to guidelines and to provide their patients with the most updated recommendations for the clinical management of hypertension...
January 2, 2019: High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension
https://read.qxmd.com/read/30589728/no-longer-failing-to-treat-heart-failure-a-guideline-update-review
#15
Jonathan Parch, Chloe Powell
Heart failure is a leading cause of hospital admissions and death in the United States and worldwide. In 2016, the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America released a joint focused guideline update for the management of patients with Stage C heart failure with reduced ejection fraction. An additional update released in 2017 reinforces the 2016 update's strong recommendation for substituting angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with an angiotensin receptor-neprilysin inhibitor to reduce morbidity and mortality in selected patients...
January 2019: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/30561613/recommendations-for-participation-in-competitive-and-leisure-time-sport-in-athletes-with-cardiomyopathies-myocarditis-and-pericarditis-position-statement-of-the-sport-cardiology-section-of-the-european-association-of-preventive-cardiology-eapc
#16
Antonio Pelliccia, Erik Ekker Solberg, Michael Papadakis, Paolo Emilio Adami, Alessandro Biffi, Stefano Caselli, Andrè La Gerche, Josef Niebauer, Axel Pressler, Christian M Schmied, Luis Serratosa, Martin Halle, Frank Van Buuren, Mats Borjesson, Francois Carrè, Nicole M Panhuyzen-Goedkoop, Hein Heidbuchel, Iacopo Olivotto, Domenico Corrado, Gianfranco Sinagra, Sanjay Sharma
Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes...
December 14, 2018: European Heart Journal
https://read.qxmd.com/read/30534142/prevalence-of-iron-deficiency-in-patients-aged-75-years-or-older-with-heart-failure
#17
Paul Mini, Bonnefoy Marc, Subtil Fabien, Michel Chuzeville
Background: The latest studies presented at the American Heart Association (AHA) meeting on heart failure and the update of the European Cardiology Society's (ECS) recommendations on heart failure in 2016 recommend intravenous iron supplementation in patients with heart failure, reduced ejection fraction and iron deficiency for improves walking performance and quality of life, and reduces morbidity. In the present study, we investigated the prevalence of iron deficiency in heart failure patients aged 75 years or older, as there is currently no data on these patients...
November 2018: Journal of Geriatric Cardiology: JGC
https://read.qxmd.com/read/30527996/pulmonary-hypertension-associated-with-left-heart-disease-updated-recommendations-of-the-cologne-consensus-conference-2018
#18
Stephan Rosenkranz, Irene M Lang, Rüdiger Blindt, Diana Bonderman, Leonhard Bruch, Gerhard P Diller, Ralf Felgendreher, Christian Gerges, Wolfgang Hohenforst-Schmidt, Stephan Holt, Christian Jung, Ingrid Kindermann, Tilmann Kramer, Wolfgang M Kübler, Veselin Mitrovic, Andreas Riedel, Andreas Rieth, Alexander Schmeisser, Rolf Wachter, Joachim Weil, Christian F Opitz
In the summer of 2016, delegates from the German Society of Cardiology (DGK), the German Respiratory Society (DGP), and the German Society of Pediatric Cardiology (DGPK) met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary hypertension (PH). These recommendations were built on the 2015 European Pulmonary Hypertension guidelines, aiming at their practical implementation, considering country-specific issues, and including new evidence, where available...
August 27, 2018: International Journal of Cardiology
https://read.qxmd.com/read/30522654/acc-aha-versus-esc-guidelines-on-dual-antiplatelet-therapy-jacc-guideline-comparison
#19
REVIEW
Davide Capodanno, Fernando Alfonso, Glenn N Levine, Marco Valgimigli, Dominick J Angiolillo
Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease (CAD) manifestations. Prescribers of DAPT are confronted with a number of challenges that include selecting the appropriate P2Y12 inhibitor and determining the optimal duration of DAPT with the scope of minimizing the risk of ischemic and bleeding complications in light of each patient's clinical characteristic and circumstance...
December 11, 2018: Journal of the American College of Cardiology
https://read.qxmd.com/read/30485612/effectiveness-of-the-european-society-of-cardiology-heart-failure-association-website-heartfailurematters-org-and-an-e-health-adjusted-care-pathway-in-patients-with-stable-heart-failure-results-of-the-e-vita-hf-randomized-controlled-trial
#20
Kim P Wagenaar, Berna D L Broekhuizen, Tiny Jaarsma, Ilse Kok, Arend Mosterd, Frank F Willems, Gerard C M Linssen, Willem R P Agema, Sander Anneveldt, Carolien M H B Lucas, Herman F J Mannaerts, Elly M C J Wajon, Kenneth Dickstein, Maarten J Cramer, Marcel A J Landman, Arno W Hoes, Frans H Rutten
BACKGROUND: Efficient incorporation of e-health in patients with heart failure (HF) may enhance health care efficiency and patient empowerment. We aimed to assess the effect on self-care of (i) the European Society of Cardiology/Heart Failure Association website 'heartfailurematters.org' on top of usual care, and (ii) an e-health adjusted care pathway leaving out 'in person' routine HF nurse consultations in stable HF patients. METHODS AND RESULTS: In a three-group parallel-randomized trial in stable HF patients from nine Dutch outpatient clinics, we compared two interventions ( heartfailurematters...
November 28, 2018: European Journal of Heart Failure
keyword
keyword
165654
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"